December 7, 2016
Here is the press release:
Surgeon General Reports Youth and Young Adult E-Cigarette Use Poses a Public Health Threat
Issues call to action to reduce e-cigarette use among young people
A new report from the U.S. Surgeon General raises public health concerns about e-cigarette use among U.S. youth and young adults. The report comes amid alarming rates of youth and young adult use of e-cigarettes; in 2015, about 1 in 6 high school students used an e-cigarette in the past month. The report finds that, while nicotine is a highly addictive drug at any age, youth and young adults are uniquely vulnerable to the long-term consequences of exposing the brain to nicotine, and concludes that youth use of nicotine in any form is unsafe. The report also finds that secondhand aerosol that is exhaled into the air by e-cigarette users can expose others to potentially harmful chemicals.
November 28, 2016
We just submitted the following comment to the FDA. The tracking number is 1k0-8tan-dl14. (PDF version)
Listing of Ingredients in Tobacco Products –
Revised Draft Guidance for Industry
Docket Number FDA-2009-D-0524
Lauren K. Lempert, Lucy Popova*, Bonnie Halpern-Felsher, Benjamin Chaffee, Neal Benowitz, Gideon St. Helen, Eunice Neeley, Stanton A. Glantz
University of California, San Francisco TCORS
*Georgia State University, School of Public Health
November 28, 2016
November 28, 2016
Stanton Glantz, Professor of Medicine and Director of the UC San Francisco Center for Tobacco Control Research and Education is seeking an individual to conduct policy research in the evolving policy environment around marijuana policy and how it interacts with tobacco control policymaking at the state and local level.
The project involves preparing detailed case studies on policy making in states with a variety of marijuana policies, including research on the development and passage (or defeat) of relevant legislation, implementation, funding and management of marijuana and tobacco control programs, efforts of public health advocates to promote public health programs, and opposition to public health policies by the marijuana and tobacco industries and their allies and surrogates. Data collection will involve researching written records, relevant laws, analyzing campaign contribution information, conducting interviews and doing field research.
November 21, 2016
It took some time for the news to make it here from Australia, but the Daily Mail reports that Ryan Gosling — star of The Nice Guys (R, Time Warner) — told a Sydney radio show that "I smoked myself out" in the film and "never want another cigarette again!"
And no wonder. TUTD reports that The Nice Guys, now on video worldwide, features:
• 24 smoking actors, including Ryan Gosling and Russell Crowe
• L&M (Philip Morris) cigarette brand display
• 400+ tobacco incidents, making it the smokiest film of the year (as of Nov. 2016)
• 1.8 billion tobacco impressions delivered to domestic theater audiences
• A smoking "disclaimer" in the closing credits of the US release.
The disclaimer states:
November 16, 2016
E-cigarette advocates love to present e-cigarettes as a disruptive technology developed in China to compete with the big cigarette companies. Lauren Dutra, Rachel Grana, and I looked in the previously secret tobacco industry documents and found that Phillip Morris had been working on what became e-cigarette technology since 1990 and had developed a functional system well before the Chinese
This work, summarized on our new paper “Philip Morris research on precursors to the modern e-cigarette since 1990” just published in Tobacco Control found
▸ Hon Lik, a Chinese pharmacist, is often cited as, in 2003, inventing the modern e-cigarette, which some see as a disruptive technology to compete with conventional cigarette companies.
▸ Philip Morris has researched nicotine aerosol technology similar to the modern e-cigarette since 1990.
▸ Philip Morris developed nicotine aerosol technology to attempt to keep health conscious smokers from using nicotine replacement while circumventing regulation and restrictions on cigarettes.
▸ In the 1990s, concerns about triggering Food and Drug Administration regulation of cigarettes led Philip orris to shift its focus towards pharmaceutical applications of aerosol technology